News & events

Close monitoring essential to ensure safety of ketamine for depression

Patients, carers and advocates say better evidence is needed on the safety of ketamine for depression after long-term use, and that those prescribed it must be closely monitored. These are the results of a study undertaken as part of a collaboration between the NIHR Maudsley Biomedical Research Centre (BRC) and NIHR Oxford Health Biomedical Research Centre (BRC). 

 

By NIHR Maudsley BRC at 30 Jul 2019